DOI: 10.36347/sjams.2023.v11i08.012

Pages: 1459-1461

The management of pregnancy-associated breast cancer is a challenge for physicians, often stemming from the mother's desire to carry the pregnancy to term despite the need for chemotherapy. 26-year-old patient, multiparous, with no particular history, followed from 20 weeks of amenorrhea (SA) for triple-negative infiltrating mammary carcinoma who underwent two courses of neo-adjuvant chemotherapy combining 5-Fluorouracil, Epirubicin and Cyclophosphamide after discussion in multidisciplinary consultation meeting (RCP) and the consent of the couple, who presented a threat of premature delivery at 34 WA, the day after their 2nd course of chemotherapy. The evolution of the pregnancy was favorable; the delivery was vaginally at 37 SA of a newborn with good neonatal adaptation. Several parameters must be considered when administering antineoplastics, hence the importance of close fetal and obstetric monitoring. A multidisciplinary approach is recommended for the therapeutic decision and follow-up.